AURORA
NAVAJAS GUTIERREZ
Researcher in the period 2009-2013
![Foto de AURORA](/img/nophoto.png)
![Foto de Instituto de Investigación Sanitaria Biocruces Bizkaia](/img/noimage_org.png)
Instituto de Investigación Sanitaria Biocruces Bizkaia
Barakaldo, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria Biocruces Bizkaia (12)
2023
-
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
Acta Neuropathologica, Vol. 145, Núm. 5, pp. 651-666
2019
-
Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia
Pharmacogenomics Journal, Vol. 19, Núm. 6, pp. 564-569
2018
-
Involvement of SNPs in miR-3117 and miR-3689d2 in childhood acute lymphoblastic leukemia risk
Oncotarget, Vol. 9, Núm. 33, pp. 22907-22914
-
Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment
Pharmacogenomics, Vol. 19, Núm. 18, pp. 1403-1412
-
Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia
Pharmacogenomics Journal, Vol. 18, Núm. 6, pp. 704-712
-
Pharmacoepigenetics in childhood acute lymphoblastic leukemia: Involvement of miRNA polymorphisms in hepatotoxicity
Epigenomics, Vol. 10, Núm. 4, pp. 409-417
2017
2016
-
MIR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia
Pharmacogenetics and Genomics, Vol. 26, Núm. 11, pp. 517-525
-
Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia
Pharmacogenomics, Vol. 17, Núm. 7, pp. 731-741
2015
-
Disseminated fusariosis and hematologic malignancies, a still devastating association. Report of three new cases
Revista Iberoamericana de Micologia, Vol. 32, Núm. 3, pp. 190-196
2014
-
Revisión de cavernomatosis múltiple: a propósito de una familia
Anales de Pediatria